Showing Results for
- Academic Journals (46,492)
Search Results
- 46,492
Academic Journals
- 46,492
- 1From:PLoS ONE (Vol. 16, Issue 12) Peer-ReviewedSARS-CoV-2 RT-PCR, the gold standard for diagnostic testing, may not be readily available or logistically applicable for routine COVID-19 testing in many rural communities in the United States. In this validation study,...
- 2From:Dermatology News (Vol. 52, Issue 2)Evidence that a SARS-CoV-2 vaccine is associated with inflammatory reactions in patients with dermal fillers has led the American Society for Dermatologic Surgery to issue a guidance outlining the potential risk and...
- 3From:Journal of Family Practice (Vol. 70, Issue 2) Peer-ReviewedPrioritized immunization is advised with the 2 COVID-19 vaccines. A third meningococcal ACWY vaccine is now the only one approved for those > 55 years. The year 2020 was challenging for public health agencies and...
- 4From:Nature Reviews Drug Discovery (Vol. 20, Issue 1) Peer-ReviewedAuthor(s): Asher Mullard Author Affiliations: COVID-19 vaccines buoy hope Barely a year since the emergence of the SARS-CoV-2 virus, multiple vaccine developers are poised to secure emergency authorization in...
- 5From:SAMJ South African Medical Journal (Vol. 111, Issue 5) Peer-ReviewedThe Democratic Republic of the Congo (DRC) declared the end of its 10th Ebola virus disease (EVD) outbreak on 25 June 2020. The outbreak was declared in North Kivu on 1 August 2018, and by the time it ended there had...
- 6From:Archives of Pediatric Neurosurgery (Vol. 3, Issue 1) Peer-ReviewedOn 11 March, the WHO confirmed coronavirus disease 2019 as a pandemic. The Director-General of the WHO called on governments to change its course by taking "urgent and aggressive action" (1). In terms of the number of...
- 7From:Nature (Vol. 590, Issue 7845) Peer-ReviewedThe country is the first to see a direct effect of vaccines working in such a large group of people. The country is the first to see a direct effect of vaccines working in such a large group of people. Author(s):...
- 8From:Saudi Medical Journal (Vol. 42, Issue 2) Peer-Reviewed16 January 2021--More than 2,800 scientists from 130 countries gathered on Friday (January 15) in a virtual forum hosted by the World Health Organization (WHO) to identify knowledge gaps and set research priorities for...
- 9From:Nature (Vol. 586, Issue 7830) Peer-ReviewedA safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic.sup.1-8. For global deployment and pandemic control, a...
- 10From:SAMJ South African Medical Journal (Vol. 111, Issue 3) Peer-Reviewed2020 changed our lives. For too many it was the end of their life. For all of us, it heralded a new reality. During 2020 my social media feed was full of people wishing the year would end. I thought that little would...
- 11From:Journal of Clinical and Scientific Research (Vol. 11, Issue 1) Peer-ReviewedByline: G. Rao, R. Ram, B. Vengamma Background: Concern about vaccine hesitancy is growing worldwide. Vaccine hesitancy can have effects for both the individual and the community, especially in the context of severe...
- 12From:Emerging Infectious Diseases (Vol. 27, Issue 11) Peer-ReviewedIn Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly before an outbreak of B.1.617.2 (Delta) variant-dominant infection. We...
- 13From:Thrombosis Journal (Vol. 19, Issue 1) Peer-ReviewedBackground Thromboembolic and bleeding events after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are major public concerns leading to vaccine hesitancy. Due to low incidence, an...
- 14From:Nature (Vol. 593, Issue 7859) Peer-ReviewedData from Qatar provide strongest evidence yet that COVID-19 vaccines can stop strains thought to pose a threat to immunization efforts. Data from Qatar provide strongest evidence yet that COVID-19 vaccines can stop...
- 15From:BMC Oral Health (Vol. 21, Issue 1) Peer-ReviewedBackground Dentists are at high risk of exposure to occupational Coronavirus Disease 2019 (COVID-19). Since vaccination is crucial to control COVID-19 pandemic, we aimed to assess COVID-19 vaccination acceptance and...
- 16From:Journal of Clinical Investigation (Vol. 131, Issue 12) Peer-ReviewedRecently, there have been several reports of SARS-CoV-2 "breakthrough" infections that have occurred in recipients of the FDA-approved SARS-CoV-2 vaccines (1). These reports have the potential to undermine public...
- 17From:Infectious Diseases and Clinical Microbiology (Vol. 3, Issue 2) Peer-ReviewedThe burden of COVID-19 on healthcare workers (HCWs) is increasing day by day, particularly in countries with high incidence. Turkey was the fourth leading country after India, the USA and Brazil that reported the highest...
- 18From:Healthcare Financial Management (Vol. 76, Issue 2) Peer-ReviewedOf nationwide job cuts in January that stemmed from refusals to get the COVID-19 vaccine, the majority were in healthcare, according to a report. Challenger, Gray & Christmas, Inc., a global outplacement and business...
- 19From:BMC Health Services Research (Vol. 22, Issue 1) Peer-ReviewedBackground People's lives were seriously affected by the emergence and the spread of the COVID-19 disease. Several vaccines were developed in record time to overcome this pandemic. However, putting an end to this...
- 20From:Cancer Therapy Advisor(HealthDay News) — Axillary lymphadenopathy, a common adverse effect of COVID-19 vaccination, is seen in 44 percent of patients undergoing breast imaging after vaccination, according to a study published in the May issue...